Some novel anticonvulsant agents derived from phthalazinedione

Arzneimittel-Forschung/Drug Research

Volumn 62, Issue 11, 2012, Pages 532-536

  Zayed, M F ^a,b   Ayyad, R R ^a  

^a Al Azhar University   (Egypt)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

1, 3, 4 oxadiazole; antiepleptics; phthalazinedione

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; 3 (2 ALKOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE 1,4(2H,3H) 1,4 DIONE; 3 (2 ETHOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; 3 (2 HYDROXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; 3 (2 ISOBUTYLOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; 3 (2 ISOPROPYLOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; 3 (2 METHOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; 3 (2 N BUTYLOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; 3 (2 N PROPYLOXYCARBONYLMETHYLTHIOXADIOZOL 5 YL)METHYL 6 IODOPHTHALAZINE (2H,3H) 1,4 DIONE; ANTICONVULSIVE AGENT; MESUXIMIDE; PENTETRAZOLE; PHENYTOIN; PHTHALAZINEDIONE DERIVATIVE; TRIMETHADIONE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; DRUG DOSE INCREASE; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTRIC SHOCK; MALE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE;

ANIMALS; ANTICONVULSANTS; MALE; MICE; MICE, INBRED ICR; PHTHALAZINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84869141131     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0032-1323758     Document Type: Article

References (19)

1. Stefan H., Feuerstein J. T. Novel anticonvulsant drugs. Pharmacol Ther: 2007; 113 165 183
2. Donner J. E., Snead C. O. New generation anticonvulsants for the treatment of epilepsy in children. NeuroRX: 2006; 3 170 180
3. Loscher W., Schmidt D. New horizons in the development of antiepileptic drugs. Epilepsy Res: 2002; 50 3 16
4. Loscher W., Schmidt D. New horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res: 2006; 69 183 272
5. Greenwood S. R. Adverse effects of antiepileptic drugs. Epilepsia: 2000; 41 42 52
6. Wong G. M., Defina A. J., Andrews R. P. Conformational analysis of clinically active anticonvulsant drugs. J Med Chem: 1986; 29 562 572
7. Pelletier C. J., Hesson P. D., Jones A. K. et al. Substituted 1,2-dihydrophthalazines: Potent, selective, and noncompetitive inhibitors of the AMPA receptor. J Med Chem: 1996; 39 343 346
8. Grasso S., Sarro D. G., Sarro D. A. et al. Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones. J Med Chem: 2000; 43 2851 2859
9. Xu W., Han F., He M. et al. Inhibition of tobacco bacterial wilt with sulfone derivatives containing an 1,3,4-oxadiazole Moiety. J Agric Food Chem: 2012; 60 1036 1041
10. Bader H., Hoops F. J., Biel H. J. et al. Antimalarial compounds related to diaminodiphenyl sulfone. J Med Chem: 1969; 12 709 711
11. Watjen F., Baker R., Engelstoff M. et al. Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines. J Med Chem: 1989; 32 2282 2291
12. Jhal K. K., Kumar Y., Shaharyar M. et al. Microwave assisted synthesis, characterization & biological evaluation of Benzimidazole substituted1,3,4-oxadiazole. Int J ChemTech Res: 2010; 2 716 727
13. Singh P., Sharma K. P., Sharma K. J. et al. Synthesis and evaluation of substituted diphenyl-1,3,4-oxadiazole derivatives for central nervous system depressant activity. Org Med Chem Lett: 2012; 2 08 1 10
14. Laznicek M., Beno P., Waisser K. et al. Quantitative chemical structure-pharmacokinetic data relationships. IV. Relationships between pharmacokinetic data and lipophilicity of iodine-substituted aromatic and arylaliphatic compounds. Cesko-Slovenska Farmacie: 1985; 34 09 353 358
15. Yanming W., Chester A. M., Guo-Feng H. et al. Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives. J mol neurosci: 2003; 20 03 255 260
16. Sivakumar R., Gnanasam K. S., Ramachandran S. et al. Pharmacological evaluation of some new 1-substituted-4 hydroxyphthalazines. Eur J med Chem: 2002; 37 793 801
17. Parsons G. C., Danysz W., Quack N. G. et al. Systemically Active Antagonists of the Glycine Site of the N-Methyl-D-aspartate Receptor: Electrophysiological, Biochemical and Behavioral Characterization. J Pharmacol Exp Ther: 1997; 283 1264 1275
18. Krall L. R., Penary K. J., White G. B. et al. Antiepileptic drug development: II. anticonvulsant drug screening. Epilepsia: 1978; 19 409 428
19. Witak T. D., Seth K. S., Baizman R. E. et al. p-Substituted N-acetyl-L-(S)- and D(R)-.alpha.-amino-N phenylsuccinimides and -glutarimides. Substituent effects on stereoselective anticonvulsant activity. J Med Chem: 1972; 15 1117 1123